File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Breast conservation therapy for invasive breast cancer in Hong Kong: Factors affecting recurrence and survival in Chinese women

TitleBreast conservation therapy for invasive breast cancer in Hong Kong: Factors affecting recurrence and survival in Chinese women
Authors
Issue Date1997
PublisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ANS
Citation
Australian And New Zealand Journal Of Surgery, 1997, v. 67 n. 2-3, p. 94-97 How to Cite?
AbstractBackground: Breast conservation therapy is an established procedure for treating invasive breast cancer. However, little has been reported in the literature about its applicability in the Chinese. This study was done to find out the local recurrence and mortality rates of such therapy among Hong Kong Chinese women. In addition, the prognostic factors were also examined. Methods: A retrospective study reviewing clinical records of breast cancer patients treated between February 1986 and September 1994 was undertaken. Results: Sixty-four female patients were identified. The follow-up period ranged from 8 to 90 months with a median of 46 months. The median age at diagnosis was 51 years and 50% of patients were postmenopausal. The median tumour size was 2.5 cm and 20 patients had involved axillary lymph nodes. Ten (16%) patients developed ipsilateral breast tumour recurrence and seven underwent salvage mastectomy. Lymphovascular permeation by tumour cells was the only factor significantly associated with recurrence. Five (8%) eventually died; the 5-year disease-free and overall survival rates were 42% and 83%, respectively. Ipsilateral breast tumour recurrence correlated with a higher mortality rate whereas adjuvant treatment with either chemotherapy or tamoxifen improved the outcome. Conclusions: Breast conservation therapy is an acceptable alternative in the treatment of breast cancer in Chinese patients.
Persistent Identifierhttp://hdl.handle.net/10722/172733
ISSN
2003 Impact Factor: 0.874
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChow, LWCen_US
dc.contributor.authorAu, GKHen_US
dc.contributor.authorPoon, RTPen_US
dc.date.accessioned2012-10-30T06:24:33Z-
dc.date.available2012-10-30T06:24:33Z-
dc.date.issued1997en_US
dc.identifier.citationAustralian And New Zealand Journal Of Surgery, 1997, v. 67 n. 2-3, p. 94-97en_US
dc.identifier.issn0004-8682en_US
dc.identifier.urihttp://hdl.handle.net/10722/172733-
dc.description.abstractBackground: Breast conservation therapy is an established procedure for treating invasive breast cancer. However, little has been reported in the literature about its applicability in the Chinese. This study was done to find out the local recurrence and mortality rates of such therapy among Hong Kong Chinese women. In addition, the prognostic factors were also examined. Methods: A retrospective study reviewing clinical records of breast cancer patients treated between February 1986 and September 1994 was undertaken. Results: Sixty-four female patients were identified. The follow-up period ranged from 8 to 90 months with a median of 46 months. The median age at diagnosis was 51 years and 50% of patients were postmenopausal. The median tumour size was 2.5 cm and 20 patients had involved axillary lymph nodes. Ten (16%) patients developed ipsilateral breast tumour recurrence and seven underwent salvage mastectomy. Lymphovascular permeation by tumour cells was the only factor significantly associated with recurrence. Five (8%) eventually died; the 5-year disease-free and overall survival rates were 42% and 83%, respectively. Ipsilateral breast tumour recurrence correlated with a higher mortality rate whereas adjuvant treatment with either chemotherapy or tamoxifen improved the outcome. Conclusions: Breast conservation therapy is an acceptable alternative in the treatment of breast cancer in Chinese patients.en_US
dc.languageengen_US
dc.publisherBlackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ANSen_US
dc.relation.ispartofAustralian and New Zealand Journal of Surgeryen_US
dc.subject.meshBreast Neoplasms - Mortality - Pathology - Therapyen_US
dc.subject.meshChemotherapy, Adjuvanten_US
dc.subject.meshDisease-Free Survivalen_US
dc.subject.meshFemaleen_US
dc.subject.meshHong Kong - Epidemiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphatic Metastasisen_US
dc.subject.meshMastectomyen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshNeoplasm Recurrence, Local - Mortalityen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshSurvival Rateen_US
dc.subject.meshTamoxifen - Therapeutic Useen_US
dc.titleBreast conservation therapy for invasive breast cancer in Hong Kong: Factors affecting recurrence and survival in Chinese womenen_US
dc.typeArticleen_US
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_US
dc.identifier.authorityPoon, RTP=rp00446en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1445-2197.1997.tb01910.x-
dc.identifier.pmid9068548-
dc.identifier.scopuseid_2-s2.0-0030986042en_US
dc.identifier.hkuros28442-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0030986042&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume67en_US
dc.identifier.issue2-3en_US
dc.identifier.spage94en_US
dc.identifier.epage97en_US
dc.identifier.isiWOS:A1997WM54900003-
dc.publisher.placeAustraliaen_US
dc.identifier.scopusauthoridChow, LWC=7202532995en_US
dc.identifier.scopusauthoridAu, GKH=7003748615en_US
dc.identifier.scopusauthoridPoon, RTP=7103097223en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats